Guy Chamberland, M.Sc., Ph.D

Guy Chamberland, M.Sc., Ph.D., Master Herbalist is Chief Executive Officer and Chief Scientific Officer of Tetra Bio-Pharma, a Canadian-based global leader in the discovery and development of cannabinoid-derived pharmaceutical products. In assuming leadership of Tetra Bio-Pharma in 2018, Chamberland was instrumental in differentiating Tetra?s approach to exploring the potential therapeutic uses of cannabis by adopting a pharmaceutical pathway built on rigorous standards that meet the inclusion requirements of regulators, medical bodies and payors. Chamberland is an acknowledged expert in the biopharmaceutical space with more than two decades of experience in drug development for the North American pharmaceutical industry, particularly in regulatory affairs and the development and management of clinical research protocols and clinical studies for botanical medicines. Chamberland is a prolific contributor to the field of botanical medicine, publishing, lecturing and conducting continuing education workshops for health professionals on the use of plants in the treatment of pain, anxiety, insomnia, and wound healing. He is a Professor of Botanical Medicine and Principles of Clinical Research at the Ecole d'Enseignement Superieur de Naturopathie du Quebec (EESNQ) and French language equivalent of the Canadian College of Naturopathic Medicine (CCNNM). He earned a diploma in Proficiency in Herbal Prescription from the Australian College of Phytotherapy, a Certified Herbalist from the Dominion College of Canada and a Master Herbalist diploma from the Dominion College of Canada. Chamberland earned a B.Sc. in Agriculture from McGill University, an M.Sc. in Veterinary Anatomy and Physiology and a Ph.D. in Biomedical Sciences (toxicology) from the University of Montreal.